Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells
- PMID: 15607966
- DOI: 10.1016/j.ccr.2004.09.033
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells
Abstract
N-Myc oncogene amplification is a frequent event in neuroblastoma and is strongly correlated with advanced disease stage and treatment failure. Similarly to c-Myc oncogenic activation, N-Myc deregulation promotes both cell proliferation and p53-dependent apoptosis by sensitizing cells to a variety of insults. Intriguingly, p53 mutations are uncommon in neuroblastomas, strongly suggesting that an alternative cooperating event circumvents this safeguard against oncogene-driven neoplasia. By performing a pangenomic cDNA microarray analysis, we demonstrate that human Twist is constantly overexpressed in N-Myc-amplified neuroblastomas. H-Twist overexpression is responsible for the inhibition of the ARF/p53 pathway involved in the Myc-dependent apoptotic response. This oncogenic cooperation of two key regulators of embryogenesis causes cell transformation and malignant outgrowth.
Similar articles
-
[Cancer cells escape from failsafe programs in a simple Twist].Bull Cancer. 2006 Mar 1;93(3):251-6. Bull Cancer. 2006. PMID: 16567311 Review. French.
-
E2F activity is essential for survival of Myc-overexpressing human cancer cells.Oncogene. 2002 Sep 19;21(42):6498-509. doi: 10.1038/sj.onc.1205828. Oncogene. 2002. PMID: 12226753
-
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.Clin Cancer Res. 2001 Nov;7(11):3481-90. Clin Cancer Res. 2001. PMID: 11705866
-
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.Oncogene. 2001 Oct 25;20(48):6983-93. doi: 10.1038/sj.onc.1204892. Oncogene. 2001. PMID: 11704823
-
E2F1 and c-Myc in cell growth and death.Cell Cycle. 2003 Jul-Aug;2(4):333-8. Cell Cycle. 2003. PMID: 12851485 Review.
Cited by
-
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1.Oncotarget. 2011 Dec;2(12):1028-42. doi: 10.18632/oncotarget.367. Oncotarget. 2011. PMID: 22184289 Free PMC article.
-
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.Cell Mol Life Sci. 2012 Oct;69(20):3429-56. doi: 10.1007/s00018-012-1122-2. Epub 2012 Sep 4. Cell Mol Life Sci. 2012. PMID: 22945800 Free PMC article. Review.
-
Coexpression of Bcl-2 with epithelial-mesenchymal transition regulators is a prognostic indicator in hepatocellular carcinoma.Med Oncol. 2012 Dec;29(4):2780-92. doi: 10.1007/s12032-012-0207-y. Epub 2012 Mar 30. Med Oncol. 2012. PMID: 22460834
-
Prognostic value of colorectal cancer biomarkers.Cancers (Basel). 2011 Apr 19;3(2):2080-105. doi: 10.3390/cancers3022080. Cancers (Basel). 2011. PMID: 24212797 Free PMC article.
-
Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.Int J Mol Sci. 2013 Oct 14;14(10):20459-77. doi: 10.3390/ijms141020459. Int J Mol Sci. 2013. PMID: 24129179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous